Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mary D. Dockery"'
Autor:
Samantha M. Sarett, Kameron V. Kilchrist, Meredith A. Jackson, Taylor E. Kavanaugh, Todd D. Giorgio, Ayisha N. Jackson, Elizabeth J. Curvino, Craig L. Duvall, Fang Yu, Thomas A. Werfel, Mary D. Dockery
Although siRNA-based nanomedicines hold promise for cancer treatment, conventional siRNA–polymer complex (polyplex) nanocarrier systems have poor pharmacokinetics following intravenous delivery, hindering tumor accumulation. Here, we determined the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3989b7dcda3899b5aed7fca4ca92143
https://europepmc.org/articles/PMC5919184/
https://europepmc.org/articles/PMC5919184/
Autor:
Mary D. Dockery, Ken Wilkens, Megan E. Poorman, Vandiver Chaplin, William A. Grissom, Charles F. Caskey, Todd D. Giorgio
Publikováno v:
Journal of Therapeutic Ultrasound
Autor:
Ken Wilkens, Charles F. Caskey, Mary D. Dockery, William A. Grissom, Megan E. Poorman, Vandiver Chaplin, Todd D. Giorgio
Publikováno v:
Journal of Therapeutic Ultrasound
Background MR-guided focused ultrasound or high-intensity focused ultrasound (MRgFUS/MRgHIFU) is a non-invasive therapeutic modality with many potential applications in areas such as cancer therapy, drug delivery, and blood-brain barrier opening. How
Autor:
Charles F. Caskey, Stephanie O. Dudzinski, Mary D. Dockery, Megan E. Poorman, Ryan Spears, Fiona E. Yull, Todd D. Giorgio, Jiro Kusunose, Whitney Barham, William A. Grissom, Vandiver Chaplin
Publikováno v:
Cancer Research. 76:A06-A06
Characterization of therapeutic response in primary and metastatic tumors is limited by endpoint studies and tissue collection. We have successfully developed a unique double-transgenic mouse model, which combines the polyoma virus middle T oncogene
Autor:
Ryan Spears, Todd D. Giorgio, Mary D. Dockery, Charles F. Caskey, William A. Grissom, Megan E. Poorman, Vandiver Chaplin
Publikováno v:
Cancer Immunology Research. 4:A086-A086
Detailed temporal characterization of in vivo response to anti-tumor immunotherapies are limited by the frequency and volume of tissue that can be practically collected. We have successfully generated a novel double-transgenic murine model, which inc